Back to EP Wealth Advisors, LLC EP Wealth Advisors, LLC

ARWRARWR
12 quarters

Position history for EP Wealth Advisors, LLCEP Wealth Advisors, LLC's holdings in ARROWHEAD PHARMACEUTICALS IN

EP Wealth Advisors, LLC holds 38,135 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $3.1M as of 2026-Q2. The position was decreased (-0.7% shares). ARWR represents 0.0% of EP Wealth Advisors, LLC's portfolio.

Current Value

$3.1M

Current Shares

38,135

Total Value Change

+$2.8M

Total Shares Change

+29,635

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
38,135
-0.7%
$3.1M0.0%$81.51
0
2026-Q1
Decreased
38,406
-0.7%
$2.4M0.0%$64.10
0
2025-Q4
Increased
38,683
+0.4%
$2.6M0.0%$67.25
26
2025-Q2
New
38,524
-
$608,6790.0%$16.08
34
2024-Q3
Exited
0
-100.0%
$00.0%$19.67
0
2024-Q2
Increased
8,844
+0.3%
$229,8560.0%$25.99
23
2024-Q1
Increased
8,819
+3.8%
$252,2230.0%$28.60
24
2023-Q4
Unchanged
8,500
0.0%
$260,1000.0%$30.60
0
2023-Q3
Increased
8,500
+851.9%
$228,3950.0%$26.87
37
2023-Q2
Decreased
893
-89.5%
$306,6760.0%$35.93
0
2023-Q1
Unchanged
8,500
0.0%
$215,9000.0%$24.43
0
2022-Q4
New
8,500
-
$344,7600.0%$40.56
33

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used